TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SCPH Stock 12 Month Forecast
There Are No Analyst Ratings for SCPH In The Last 3 Months.
Highest Price Target―
Average Price Target―
Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
SCPH Financial Forecast
SCPH Earnings Forecast
Next quarter’s earnings estimate for SCPH is -$0.24 with a range of -$0.26 to -$0.23. The previous quarter’s EPS was -$0.34. SCPH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year SCPH has Performed in-line its overall industry.
Next quarter’s earnings estimate for SCPH is -$0.24 with a range of -$0.26 to -$0.23. The previous quarter’s EPS was -$0.34. SCPH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate ― of the time in the same period. In the last calendar year SCPH has Performed in-line its overall industry.
SCPH Sales Forecast
Next quarter’s sales forecast for SCPH is $19.21M with a range of $18.80M to $19.53M. The previous quarter’s sales results were $16.04M. SCPH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year SCPH has Performed in-line its overall industry.
Next quarter’s sales forecast for SCPH is $19.21M with a range of $18.80M to $19.53M. The previous quarter’s sales results were $16.04M. SCPH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates ― of the time in the same period. In the last calendar year SCPH has Performed in-line its overall industry.
scPharmaceuticals (SCPH) PT Lowered to $13 at JefferiesJefferies analyst Glen Santangelo lowered the price target on scPharmaceuticals (NASDAQ: SCPH) to $13.00 (from $16.00) while maintaining a Buy rating.
scPharmaceuticals (SCPH) PT Lowered to $13 at JefferiesJefferies analyst Glen Santangelo lowered the price target on scPharmaceuticals (NASDAQ: SCPH) to $13.00 (from $16.00) while maintaining a Buy rating.
Stocks with the Highest Top Analyst Consensus in the Sector
Find stocks in the sector that are highly recommended by Top Performing Analysts.
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +3.28% per trade.
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +5.87% per trade.
Copying Roanna Ruiz's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +2.52% per trade.
trades and holding each position for 2 Years would result in 55.56% of your transactions generating a profit, with an average return of +7.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SCPH Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
10
13
6
5
5
Buy
5
5
1
2
2
Hold
4
5
5
6
12
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
23
12
13
19
In the current month, SCPH has received 7Buy Ratings, 12Hold Ratings, and 0Sell Ratings. SCPH average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
SCPH Stock Forecast FAQ
What is SCPH’s average 12-month price target, according to analysts?
Currently, no data Available
What is SCPH’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SCPH, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SCPH a Buy, Sell or Hold?
Currently, no data Available
What is Scpharmaceuticals’s price target?
Currently, no data Available
What do analysts say about Scpharmaceuticals?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of SCPH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.